These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8284888)

  • 1. High attrition rate with intracavernous injection of prostaglandin E1 for impotency.
    Irwin MB; Kata EJ
    Urology; 1994 Jan; 43(1):84-7. PubMed ID: 8284888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction.
    Kunelius P; Lukkarinen O
    Int J Impot Res; 1999 Feb; 11(1):21-4. PubMed ID: 10098949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates.
    Polito M; d'Anzeo G; Conti A; Muzzonigro G
    BJU Int; 2012 Dec; 110(11 Pt C):E954-7. PubMed ID: 23078100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostaglandin E1 versus sildenafil in the management of erectile dysfunction].
    Wang ZL; Li B; Yan JZ; Dong SG
    Zhonghua Nan Ke Xue; 2002; 8(3):198-200. PubMed ID: 12478843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections.
    Nandipati K; Raina R; Agarwal A; Zippe CD
    Int J Impot Res; 2006; 18(5):446-51. PubMed ID: 16482200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracavernosal prostaglandin E1 self vs office injection therapy in patients with erectile dysfunction.
    El-Sakka AI
    Int J Impot Res; 2006; 18(2):180-5. PubMed ID: 16163370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
    Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
    Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: results of a multicenter European study. The Sildenafil Multicenter Study Group.
    Giuliano F; Montorsi F; Mirone V; Rossi D; Sweeney M
    J Urol; 2000 Sep; 164(3 Pt 1):708-11. PubMed ID: 10953130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y; Lidgi S; Moskovitz B; Levin RD
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracavernous injection of prostaglandin E1 is effective in patients with erectile dysfunction not responding to phosphodiseterase 5 inhibitors.
    Nagai A; Kusumi N; Tsuboi H; Ishii K; Saika T; Nasu Y; Kumon H
    Acta Med Okayama; 2005 Dec; 59(6):279-80. PubMed ID: 16418771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.
    He L; Wen J; Jiang X; Chen H; Tang Y
    Andrologia; 2011 Jun; 43(3):208-12. PubMed ID: 21486416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of penile fibrosis in intracavernosal prostaglandin E1 injection therapy: a follow-up of 44 patients.
    Chew KK; Stuckey BG
    Int J Impot Res; 2003 Apr; 15(2):94-8. PubMed ID: 12789387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1 long-term self-injection programme for treatment of erectile dysfunction--a follow-up of at least 5 years.
    Hauck EW; Altinkilic BM; Schroeder-Printzen I; Rudnick J; Weidner W
    Andrologia; 1999; 31 Suppl 1():99-103. PubMed ID: 10643527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1 as treatment for erectile failure in elderly men.
    Godschalk MF; Chen J; Katz PG; Mulligan T
    J Am Geriatr Soc; 1994 Dec; 42(12):1263-5. PubMed ID: 7983289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
    Amar E; Kobelinsky M; Khoury R; Sarkis P; Bouyer I; Dauphin A; Delmas V; Boccon-Gibod L
    Prog Urol; 1993 Dec; 3(6):971-8. PubMed ID: 8305940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: intracavernous injection of prostaglandin E1.
    JAMA; 1991 Jun; 265(24):3321-3. PubMed ID: 2046116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavernous self-injection therapy for the treatment of erectile dysfunction.
    Chiang HS; Wen TC; Wu CC; Chiang WH
    J Formos Med Assoc; 1992 Sep; 91(9):898-901. PubMed ID: 1363391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of PGE1 in the treatment of erectile deficiency].
    Arena F; Peracchia G; Di Stefano C; Cortellini P
    Acta Biomed Ateneo Parmense; 1996; 67(1-2):49-53. PubMed ID: 10021734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracavernous self-injection of prostaglandin E1 in the therapy of erectile dysfunction.
    Porst H; van Ahlen H; Block T; Halbig W; Hautmann R; Löchner-Ernst D; Rudnick J; Staehler G; Weber HM; Weidner W
    Vasa Suppl; 1989; 28():50-6. PubMed ID: 2609244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.